Moderna (MRNA)
Commercializes mRNA respiratory vaccines while developing oncology and rare-disease therapies.
$189.13
vs last close+6.57 (+3.60%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 81.06% | 323.61M shares | |
|---|---|---|---|
| 862 holders · as of Jun 30, 2026 | |||
| Insiders | 7.14% | 28.50M shares | |
| 12 holders · as of Sep 16, 2026 | |||
| Strategic holders | 6.93% | 27.66M shares | |
| 1 holder · as of Feb 4, 2022 | |||
| Other | 4.87% | 19.47M shares | |
| remainder | |||
399.24M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
862 holders · 323.61M shares · 153 new positions · 405 increased · 254 reduced · 91 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| FMR LLC | 51.86M | 12.99% | +6.19M | Aug 13, 2026 |
| BlackRock, Inc. | 30.60M | 7.66% | +963.5K | Aug 7, 2026 |
| Vanguard Capital Management LLC | 23.21M | 5.81% | +336.3K | Aug 13, 2026 |
| Capital World Investors | 22.28M | 5.58% | +3.58M | Aug 12, 2026 |
| Baillie Gifford & Co | 18.21M | 4.56% | −1.78M | Aug 6, 2026 |
| State Street Corp | 15.73M | 3.94% | +864.8K | Aug 7, 2026 |
| Vanguard Portfolio Management LLC | 15.58M | 3.90% | −35.1K | Aug 13, 2026 |
| Geode Capital Management, LLC | 9.71M | 2.43% | +275.2K | Aug 12, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| FMR LLC | 10.60% | 41.30M | 13G | Feb 6, 2026 |
| Vanguard Capital Management | 6.53% | 25.93M | 13G | Apr 30, 2026 |
| Capital World Investors | 5.60% | 22.28M | 13G | Aug 12, 2026 |
| Baillie Gifford & Co | 5.30% | 20.58M | 13G | Feb 9, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Sep 15, 2026 | Stephen Hogeofficer: President | Sale | 40,281 | $146.07 | 1,562,029 |
| Sep 14, 2026 | Stephen Hogeofficer: President | Sale | 40,294 | $144.13 | 1,525,858 |
| Sep 10, 2026 | James M. Mockofficer: Chief Financial Officer | Sale · 2 lots | 34,836 | $134.49 | 59,375 |
| Sep 1, 2026 | Shannon Thyme Klingerofficer: Chief Legal Officer | Sale | 3,471 | $139.95 | 74,129 |
| Aug 5, 2026 | Stephane Banceldirector, officer: Chief Executive Officer | Sale · 4 lots | 499,246 | $57.52 | 6,187,791 |
| Jul 15, 2026 | Stephen Hogeofficer: President | Sale | 53,336 | $67.60 | 1,483,848 |
| Jun 15, 2026 | Stephen Hogeofficer: President | Sale | 53,336 | $51.37 | 1,483,848 |
| Jun 4, 2026 | Shannon Thyme Klingerofficer: Chief Legal Officer | Sale | 3,471 | $50.00 | 67,468 |
| May 21, 2026 | Noubar Afeyandirector | Sale | 9,263 | $46.84 | 3,924 |
| May 15, 2026 | Stephen Hogeofficer: President | Sale | 53,336 | $48.40 | 1,477,997 |
House and Senate disclosures
| Member | Type | Amount | Owner | Traded | Disclosed |
|---|---|---|---|---|---|
| Rep. Maria Elvira Salazar · FL27 | Purchase | $1,001 – $15,000 | Aug 19, 2026 | Sep 10, 2026 |